SPRINGWORKS THERAPEUTICS, INC. Retained Earnings
SPRINGWORKS THERAPEUTICS, INC. had Retained Earnings of -$1.24 billion as of 2025-03-31, per its 10-Q filed 2025-05-09.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-05-09
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$1.24B.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$1.15B.
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$1.08B.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$1.02B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-03-31 | -$1.24B 10-Q · filed 2025-05-09 |
| 2024-12-31 | -$1.15B 10-Q · filed 2025-05-09 |
| 2024-09-30 | -$1.08B 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$1.02B 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$982.42M 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$895.03M 10-K · filed 2025-02-20 |
| 2023-09-30 | -$800.71M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$721.27M 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$643.35M 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$569.93M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$495.75M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$423.36M 10-Q · filed 2022-08-04 |
| 2022-03-31 | -$354.31M 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$292.51M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$236.44M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$195.40M 10-Q · filed 2021-08-04 |
| 2021-03-31 | -$148.39M 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$118.60M 10-K · filed 2022-02-24 |
| 2020-09-30 | -$129.88M 10-Q · filed 2020-11-12 |
| 2020-06-30 | -$108.22M 10-Q · filed 2020-08-12 |
| 2020-03-31 | -$88.32M 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$73.03M 10-K · filed 2021-02-25 |
| 2019-09-30 | -$56.81M 10-Q · filed 2019-11-12 |
| 2018-12-31 | -$22.45M 10-K · filed 2020-03-12 |